Mi Z, Jackson E K
Center for Clinical Pharmacology, Departments of Pharmacology and Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
J Pharmacol Exp Ther. 1998 Dec;287(3):926-30.
In the rat kidney, exogenous adenosine-3'-5'-monophosphate (cAMP) is converted to adenosine via the metabolism of cAMP to adenosine-5'-monophosphate by phosphodiesterase and adenosine-5'-monophosphate to adenosine by 5'-nucleotidase. Our purpose was to investigate whether in the rat kidney adenosine is synthesized from endogenous cAMP via the same pathway. Rat kidneys were perfused with Tyrode's solution, and stabilized for 3 hr to minimize basal renal purine secretion. In control experiments (n = 6), the renal venous secretion rate of adenosine, inosine, hypoxanthine and Sigmapurines (adenosine + inosine + hypoxanthine) did not change over the two 10-min experimental periods. In contrast, the beta adrenoceptor agonist (+/-)-isoproterenol (1 and 10 microM added to the perfusate) caused a significant (1-factor analysis of variance with repeated measures; n = 31) increase in the renal venous secretion of adenosine (P <.0001), inosine (P <.0007), hypoxanthine (P <.0007) and Sigmapurines (P <.0001) as measured by high-performance liquid chromatography with ultraviolet detection. The Sigmapurines was the most discriminating index of isoproterenol-induced changes in purine release, and the renal venous secretion of Sigmapurines was significantly (2-factor analysis of variance with repeated measures) attenuated by inhibition of beta adrenoceptors with propranolol (.1 microM, n = 6; P <.05), phosphodiesterase with 3-isobutyl-1-methylxanthine (1 mM, n = 5; P <.002) and 5'-nucleotidase with alpha, beta-methyleneadenosine-5'-diphosphate (0.1 mM, n = 5; P <.03). Our data indicate that activation of beta adrenoceptors increases purine biosynthesis in the rat kidney via a mechanism that involves phosphodiesterase and 5'-nucleotidase. These results support the existence of an endogenous cAMP-adenosine pathway in the rat kidney.
在大鼠肾脏中,外源性3',5'-环磷酸腺苷(cAMP)通过磷酸二酯酶将cAMP代谢为5'-单磷酸腺苷以及5'-核苷酸酶将5'-单磷酸腺苷代谢为腺苷,从而转化为腺苷。我们的目的是研究在大鼠肾脏中腺苷是否通过相同途径由内源性cAMP合成。用台氏液灌注大鼠肾脏,并使其稳定3小时以尽量减少基础肾嘌呤分泌。在对照实验(n = 6)中,在两个10分钟的实验期内,腺苷、肌苷、次黄嘌呤和总嘌呤(腺苷 + 肌苷 + 次黄嘌呤)的肾静脉分泌率没有变化。相比之下,β肾上腺素能受体激动剂(±)-异丙肾上腺素(向灌注液中添加1和10 μM)导致通过高效液相色谱-紫外检测法测定的腺苷(P <.0001)、肌苷(P <.0007)、次黄嘌呤(P <.0007)和总嘌呤(P <.0001)的肾静脉分泌显著增加(重复测量的单因素方差分析;n = 31)。总嘌呤是异丙肾上腺素诱导的嘌呤释放变化中最具区分性的指标,用普萘洛尔(.1 μM,n = 6;P <.05)抑制β肾上腺素能受体、用3-异丁基-1-甲基黄嘌呤(1 mM,n = 5;P <.002)抑制磷酸二酯酶以及用α,β-亚甲基腺苷-5'-二磷酸(0.1 mM,n = 5;P <.03)抑制5'-核苷酸酶可使总嘌呤的肾静脉分泌显著减弱(重复测量的双因素方差分析)。我们的数据表明,β肾上腺素能受体的激活通过涉及磷酸二酯酶和5'-核苷酸酶的机制增加大鼠肾脏中的嘌呤生物合成。这些结果支持大鼠肾脏中存在内源性cAMP-腺苷途径。